Diagnostics for the Real World (United States)
- World rank, all time
- #23,728 of 34,923
- Rank in United States
- #4,936 of 7,310
- Research works
- 162 ▲ 130% vs 2018-21
- Citations
- 5.7k 35.4 per fractional work
- Top-10% rate
- 11.7% all institutions 10.0%
- vs its own fields
- 1.11× 1.00× is exactly expected
- Open access
- 49% world 40%
- International
- 35% world 18%
Which fields of science does Diagnostics for the Real World (United States) work in?
In 2022-now, 70% of research at Diagnostics for the Real World (United States) is in Health Sciences, 11% in Physical Sciences. Its largest fields are Medicine (67%), Engineering (5%), Biochemistry, Genetics and Molecular Biology (5%). It does 2.7× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 24 fields, with their numbers
- Health Sciences4370.3%
- Medicine4167.0%
- Health Professions12.4%
- Veterinary00.5%
- Nursing00.2%
- Dentistry00.2%
- Physical Sciences711.1%
- Engineering35.1%
- Computer Science22.7%
- Mathematics11.6%
- Physics and Astronomy10.9%
- Materials Science00.4%
- Environmental Science00.2%
- Earth and Planetary Sciences00.1%
- Chemistry00.1%
- Social Sciences610.1%
- Life Sciences58.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 4.0×. Every wedge is a field page.
All 24 fields, with their numbers
- Veterinary3.98×0 works
- Medicine3.49×41 works
- Pharmacology, Toxicology and Pharmaceutics3.35×1 works
- Immunology and Microbiology1.88×1 works
- Economics, Econometrics and Finance1.43×2 works
- Mathematics1.34×1 works
- Decision Sciences1.30×1 works
- Biochemistry, Genetics and Molecular Biology0.89×3 works
- Health Professions0.89×1 works
- Physics and Astronomy0.40×0 works
- Nursing0.40×0 works
- Dentistry0.38×0 works
- Computer Science0.35×2 works
- Engineering0.34×3 works
- Psychology0.28×0 works
- Social Sciences0.28×2 works
- Arts and Humanities0.25×0 works
- Business, Management and Accounting0.19×0 works
- Neuroscience0.12×0 works
- Materials Science0.12×0 works
- Agricultural and Biological Sciences0.11×0 works
- Earth and Planetary Sciences0.09×0 works
- Chemistry0.06×0 works
- Environmental Science0.04×0 works
- Veterinary 4.0×
- Medicine 3.5×
- Pharmacology, Toxicology and Pharmaceutics 3.4×
- Immunology and Microbiology 1.9×
- Economics, Econometrics and Finance 1.4×
- Mathematics 1.3×
- Decision Sciences 1.3×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Health Professions 0.9×
- Physics and Astronomy 0.4×
- Nursing 0.4×
- Dentistry 0.4×
- Computer Science 0.3×
- Engineering 0.3×
- Psychology 0.3×
- Social Sciences 0.3×
- Arts and Humanities 0.2×
- Business, Management and Accounting 0.2×
- Neuroscience 0.1×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Chemistry 0.1×
- Environmental Science 0.0×
Who are the top researchers at Diagnostics for the Real World (United States)?
Ranked on the quality score, Robert Sedgley lead among researchers whose main affiliation is Diagnostics for the Real World (United States).
- 1
Robert Sedgley
United States · #1,740,453 worldwide 182 citations · 21 works
Which keywords describe research at Diagnostics for the Real World (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Cardiovascular Disease, Insulin Resistance, Obesity, Metabolic Syndrome, Global Burden, Clinical Trials and Heart Failure.
- Sepsis
- Global Access
- Cardiovascular Events
- Adverse Drug Reactions
- Prognosis
- Global Prevalence
- Lifestyle Intervention
- Critical Care
- Immune Response
- Chronic Kidney Disease
- ACE2 Receptor
- Radiotherapy
- Quality of Life
- Heart Failure
- Insulin Resistance
- Biomarkers
- Clinical Trials
- Pandemic
- Metabolic Syndrome
- Cardiovascular Disease
- Epidemiology
- Inflammation
- Obesity
- Chemotherapy
- Risk Factors
- Global Burden
- Diabetes
- Management
- Clinical Guidelines
- Clinical Practice Guidelines
- Atherosclerosis
- SARS-CoV-2
- Cancer Treatment
- Hypertension
- Cardiovascular Risk
- Glucose Metabolism
- Thrombosis
- Autoantibodies
- Cholesterol
- Infection
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology10▲ 3.9×38 topics
- Cardiovascular Disease5▲ 6.9×18 topics
- Inflammation3▲ 2.3×25 topics
- Metabolic Syndrome3▲ 5.2×12 topics
- Obesity3▲ 5.5×9 topics
- Pandemic2▲ 4.0×4 topics
- Chemotherapy2▲ 5.4×12 topics
- Clinical Trials2▲ 5.7×12 topics
- Risk Factors2▲ 3.5×12 topics
- Biomarkers2▲ 5.3×6 topics
- Global Burden2▲ 6.8×7 topics
- Insulin Resistance2▲ 8.0×7 topics
- Diabetes2▲ 6.9×9 topics
- Heart Failure2▲ 7.6×9 topics
- Management2▲ 4.0×11 topics
- Quality of Life2▲ 2.3×10 topics
- Clinical Guidelines2▲ 11×7 topics
- Radiotherapy2▲ 7.2×5 topics
- Clinical Practice Guidelines2▲ 5.0×8 topics
- ACE2 Receptor2▲ 11×2 topics
- Atherosclerosis2▲ 9.3×5 topics
- Chronic Kidney Disease2▲ 10×6 topics
- SARS-CoV-22▲ 8.3×2 topics
- Immune Response2▲ 4.1×7 topics
- Cancer Treatment1▲ 9.1×3 topics
- Critical Care1▲ 9.0×5 topics
- Hypertension1▲ 7.1×5 topics
- Lifestyle Intervention1▲ 23×2 topics
- Cardiovascular Risk1▲ 6.4×5 topics
- Global Prevalence1▲ 20×2 topics
- Glucose Metabolism1▲ 20×2 topics
- Prognosis1▲ 6.0×6 topics
- Thrombosis1▲ 7.3×5 topics
- Adverse Drug Reactions1▲ 32×2 topics
- Autoantibodies1▲ 8.0×4 topics
- Cardiovascular Events1▲ 15×3 topics
- Cholesterol1▲ 13×2 topics
- Global Access1▲ 22×2 topics
- Infection1▲ 7.2×3 topics
- Sepsis1▲ 10×2 topics
Which research topics does Diagnostics for the Real World (United States) publish most on?
By volume in 2022-now: Diabetes, Cardiovascular Risks, and Lipoproteins, Advances in Oncology and Radiotherapy, COVID-19 Clinical Research Studies and Blood Pressure and Hypertension Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
- 2 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 1 works
- 3 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 4 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 1 works
- 5 Respiratory viral infections research Epidemiology 1 works
- 6 Immune responses and vaccinations Immunology 1 works
- 7 Influenza Virus Research Studies Epidemiology 1 works
- 8 Sepsis Diagnosis and Treatment Epidemiology 1 works
- 9 Pharmacovigilance and Adverse Drug Reactions Toxicology 1 works
- 10 Pneumonia and Respiratory Infections Epidemiology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Diagnostics for the Real World (United States)'s research output changed?
Output in 2022-2025 was 130% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Diagnostics for the Real World (United States) as a percentage of every work published that year, 0.00022% in 2024.
Fractional works of Diagnostics for the Real World (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Sunnyvale
- Fairchild Semiconductor (United States)
- Advanced Micro Devices (United States)
- Yahoo (United States)
- Fujitsu (United States)
- United Microelectronics (United States)
- Juniper Networks (United States)
- Eloret (United States)
- NetApp (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Diagnostics for the Real World (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
